About this item:

220 Views | 195 Downloads

Author Notes:

Corresponding Author: Alanna M. Chamberlain, PhD, MPH. Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. chamberlain.alanna@mayo.edu; Phone: 1-507-293-3247; Fax: 1-507-284-1516

We thank Kay Traverse, Susan Stotz, and Dawn Schubert, for assistance with data collection and Deborah Strain for secretarial assistance.

Alanna M. Chamberlain is a Co-Investigator of the Rochester Epidemiology Project (R01 AG034676).

All other authors report no conflict of interest.

Subjects:

Research Funding:

This work was supported by grants from the American Heart Association (11SDG7260039) and the National Institute on Aging (R01 AG034676).

Additional support was provided by the American Heart Association (16EIA26410001) to Dr. Alonso.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Atrial fibrillation
  • Atrial flutter
  • Heartfailure
  • Epidemiology
  • Outcomes
  • ROCHESTER EPIDEMIOLOGY PROJECT
  • FOLLOW-UP
  • CARDIOVASCULAR EVENTS
  • MORTALITY
  • DISEASE
  • ASSOCIATION
  • POPULATION
  • MANAGEMENT
  • SURVIVAL
  • HISTORY

No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction

Tools:

Journal Title:

Heart Rhythm

Volume:

Volume 14, Number 6

Publisher:

, Pages 791-798

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Background Patients with atrial fibrillation (AF) experience an increased risk of heart failure (HF). However, data are lacking on current trends in the risk of HF after AF. Objective The purpose of this study was to describe the temporal trends in HF occurrence after AF in a community cohort of patients with incident AF from 2000 to 2013. Methods Cox regression was used to examine the association of year of AF diagnosis with HF and the predictors of developing HF after AF. Results Among 3491 AF patients without prior HF, 750 (21%) developed incident HF over mean follow-up of 3.7 years. Among those with an echocardiogram, 422 (61%) had HF with preserved ejection fraction (HFpEF), and 270 (39%) had HF with reduced ejection fraction (HFrEF). After adjusting for demographics and comorbidities, the risk of developing HF did not change over time (hazard ratio [HR] (95% confidence interval [CI]) per year of AF diagnosis: 1.01 (0.98–1.03) overall; 1.00 (0.98–1.03) for HFpEF; 1.00 (0.96–1.03) for HFrEF). Increasing age, obesity, smoking, diabetes, chronic pulmonary disease, and renal disease were predictors of developing HF. Compared to the Olmsted County, Minnesota, population, a substantial excess risk of developing HF was observed after AF diagnosis [standardized morbidity ratio (95% CI): 9.60 (7.44–12.19), 2.13 (1.56–2.84), and 1.70 (1.34–2.14) at 90 days, 1 year, and 3 years after diagnosis]. Conclusion In the community, HF is a frequent adverse outcome among patients with AF, and HFpEF is more common than HFrEF. The rates of HF after AF have not declined, thus highlighting the importance of continued efforts to improve outcomes in AF.

Copyright information:

© 2017 Heart Rhythm Society

Export to EndNote